A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis

Amino Acids

Volumn 41, Issue 4, 2011, Pages 969-979

  Guelzim, Najoua ^a,b   Mariotti, François ^a,b,c   Martin, Pascal G P ^c   Lasserre, Frédéric ^c   Pineau, Thierry ^c   Hermier, Dominique ^a,b  

^a INRA Institut National de la Recherche Agronomique   (France)

^b AGROPARISTECH   (France)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

Linolenic acid; Amino acids; Metabolic syndrome; N 3 PUFA; Urea

Indexed keywords

ARGINASE; ARGININE; CITRULLINE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SATURATED FATTY ACID; UREA;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT INTAKE; HORMONE DEFICIENCY; LIVER; MALE; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; URINE;

ALPHA-LINOLENIC ACID; AMINO ACIDS; ANIMALS; ARGINASE; ARGININE; BIOLOGICAL MARKERS; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PPAR ALPHA; UREA;

MUS;

EID: 83255176985     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0797-7     Document Type: Article

References (43)

1. Blouet C, Mariotti F, Mathe V, Tome D, Huneau JF (2007) Nitric oxide bioavailability and not production is first altered during the onset of insulin resistance in sucrose-fed rats. Exp Biol Med (Maywood) 232:1458-1464
2. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Luscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ (2005) Endothelial function and dysfunction. Part II. Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:233-246
3. Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J (2009) PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol 296:H719-H727
4. Chotechuang N, Azzout-Marniche D, Bos C, Chaumontet C, Gausseres N, Steiler T, Gaudichon C, Tome D (2009) mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat. Am J Physiol Endocrinol Metab 297:E1313-E1323
5. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH (2008) The metabolic syndrome. Endocr Rev 29:777-822
6. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T (1998) Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273:29577-29585
7. Edgar AD, Tomkiewicz C, Costet P, Legendre C, Aggerbeck M, Bouguet J, Staels B, Guyomard C, Pineau T, Barouki R (1998) Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. Toxicol Lett 98:13-23
8. Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13:156-159
9. Fleming I, Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284:R1-R12.
10. Forstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459:923-939
11. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349:837-842
12. Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080
13. Hachem SB, Mooradian AD (2006) Familial dyslipidaemias: an overview of genetics, pathophysiology and management. Drugs 66:1949-1969
14. Harris WS, Rambjor GS, Windsor SL, Diederich D (1997) n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 65:459-464
15. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489-1498
16. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-424
17. Kersten S, Mandard S, Escher P, Gonzalez FJ, Tafuri S, Desvergne B, Wahli W (2001) The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J 15:1971-1978
18. Kim JA, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888-1904
19. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022
20. Li P, Kim SW, Li X, Datta S, Pond WG, Wu G (2008) Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide 19:259-265
21. Linz W, Wohlfart P, Baader M, Breitschopf K, Falk E, Schafer HL, Gerl M, Kramer W, Rutten H (2009) The peroxisome proliferator- activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats. Acta Pharmacol Sin 30:935-946
22. Luiking YC, Deutz NE (2003) Isotopic investigation of nitric oxide metabolism in disease. Curr Opin Clin Nutr Metab Care 6:103-108
23. Magne J, Huneau JF, Delemasure S, Rochette L, Tome D, Mariotti F (2009) Whole-body basal nitric oxide production is impaired in postprandial endothelial dysfunction in healthy rats. Nitric Oxide 21:37-43
24. Makowski L, Noland RC, Koves TR, Xing W, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Muoio DM (2009) Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J 23:586-604
25. Mandard S, Muller M, Kersten S (2004) Peroxisome proliferatoractivated receptor alpha target genes. Cell Mol Life Sci 61:393-416
26. Mandard S, Stienstra R, Escher P, Tan NS, Kim I, Gonzalez FJ, Wahli W, Desvergne B, Muller M, Kersten S (2007) Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors. Cell Mol Life Sci 64:1145-1157
27. Mariotti F, Mahe S, Luengo C, Benamouzig R, Tome D (2000) Postprandial modulation of dietary and whole-body nitrogen utilization by carbohydrates in humans. Am J Clin Nutr 72:954-962
28. Martin PGP, Guillou H, Lasserre F, Déjean S, Lan A, Pascussi JM, SanCristobal M, Legrand P, Besse P, Pineau T (2007) Novel aspects of PPARa mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology 45:767-777
29. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM Jr, Bruckner UB (1997) Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1:177-189
30. Morise A, Thomas C, Landrier JF, Besnard P, Hermier D (2009) Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in male and female mice. Eur J Nutr 48:465-473
31. Morris SM Jr (2009) Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 157:922-930
32. Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, Romanelli AJ, Rossbacher JC, Moore IK, Regittnig W, Munoz DS, Kim JH, Shulman GI (2007) n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor- alpha-dependent manner. Diabetes 56:1034-1041
33. Newaz MA, Ranganna K, Oyekan AO (2004) Relationship between PPARalpha activation and NO on proximal tubular Na? transport in the rat. BMC Pharmacol 4:1.
34. Newaz M, Blanton A, Fidelis P, Oyekan A (2005) NAD(P)H oxidase/ nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat Res 579:163-171
35. Omura M, Kobayashi S, Mizukami Y, Mogami K, Todoroki-Ikeda N, Miyake T, Matsuzaki M (2001) Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 487:361-366
36. Patsouris D, Mandard S, Voshol PJ, Escher P, Tan NS, Havekes LM, Koenig W, Marz W, Tafuri S, Wahli W, Muller M, Kersten S (2004) PPARalpha governs glycerol metabolism. J Clin Invest 114:94-103
37. Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356
38. Robinson E, Grieve DJ (2009) Significance of peroxisome proliferator- activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 122:246-263
39. Sekine S, Sasanuki S, Aoyama T, Takeuchi H (2007) Lowering systolic blood pressure and increases in vasodilator levels in SHR with oral alpha-linolenic acid administration. J Oleo Sci 56:341-345
40. Sheikh K, Camejo G, Lanne B, Halvarsson T, Landergren MR, Oakes ND (2007) Beyond lipids, pharmacological PPAR{alpha} activation has important effects on amino acid metabolism as studied in the rat. Am J Physiol Endocrinol Metab 292:E1157- E1165 Singh TU, Kathirvel K, Choudhury S, Garg SK, Mishra SK (2010) Eicosapentaenoic acid-induced endothelium-dependent and -independent relaxation of sheep pulmonary artery. Eur J Pharmacol 636:108-113
41. Touyz RM, Schiffrin EL (2006) Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul Pharmacol 45:19-28
42. Vassault A, Cherruau B, Labbe D, Alabrune B, Baltassat P, Bonete R, Carroger G, Costantini S, Georges P, Giroud C et al (1992) Serum creatinine assay: results of a multicentric study with 16 analytical systems. Ann Biol Clin (Paris) 50:81-95
43. Zhang W, Wang R, Han SF, Bu L, Wang SW, Ma H, Jia GL (2007) Alpha-linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/ eNOS pathway. Nutrition 23:762-770